ProKidney Corp.
Last updated September 27, 2026
Organization details
- Legal name
- ProKidney Corp.
- Former names
- Social Capital Suvretta Holdings Corp. III
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Winston-Salem
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- PROK
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001850270
- EIN
- 98-1586514
Board of directors
-
Alan Lotvin · DirectorSince 2023
-
Brian Jg Pereira · DirectorSince 2023
-
Bruce Culleton · Director · Chief Executive OfficerSince 2023
-
Jennifer A. Fox · DirectorSince 2023
- Since 2023
-
Pablo G. Legorreta · DirectorSince 2023
-
Santos Jose Ignacio Jimenez · DirectorSince 2023
-
Timothy Bertram · Director · Chief Executive OfficerSince 2023
-
Uma Sinha · DirectorSince 2023
-
William F. Doyle · DirectorSince 2023
Chief executives
Bruce Culleton
· Chief Executive Officer
Dates unknown
Timothy Bertram
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.8%
-
99.3%
-
99.7%
Board connections
3 of this board's directors also sit on 9 other boards.
- via John Maraganore
- via John Maraganore
- via William F. Doyle
- via John Maraganore
- via John Maraganore
- via William F. Doyle
- via John Maraganore
- via Pablo G. Legorreta
- via John Maraganore
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $2,951,506
- 10 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 20, 2026 | Brian Jg Pereira Director | Open-market sale | −222,948 | $1.42 | $316,564 |
| Aug 20, 2026 | Brian Jg Pereira Director | Open-market sale | −27,052 | $1.42 | $38,411 |
| Aug 19, 2026 | Brian Jg Pereira Director | Open-market sale | −222,949 | $1.44 | $321,203 |
| Aug 19, 2026 | Brian Jg Pereira Director | Open-market sale | −27,051 | $1.44 | $38,972 |
| Aug 18, 2026 | Brian Jg Pereira Director | Open-market sale | −229,338 | $1.37 | $314,468 |
| Aug 18, 2026 | Brian Jg Pereira Director | Open-market sale | −27,826 | $1.37 | $38,155 |
| Aug 4, 2026 | Brian Jg Pereira Director | Derivative conversion | +81,929 | — | — |
| Aug 4, 2026 | Brian Jg Pereira Director | Derivative conversion | +675,235 | — | — |
| Jun 12, 2026 | Girolamo Todd C Officer (Chief Legal Officer) | Derivative conversion | +163,857 | — | — |
| Apr 28, 2026 | Control Empresarial de Capitales S.A. de C.V. 10% owner, Add'l Rep. Persons-see Ex.99-1 | Derivative conversion | +63,118,645 | — | — |
| Nov 13, 2025 | Brian Jg Pereira Director | Open-market sale | −447,803 | $2.37 | $1,061,293 |
| Nov 13, 2025 | Brian Jg Pereira Director | Open-market sale | −54,333 | $2.37 | $128,769 |
| Nov 12, 2025 | Brian Jg Pereira Director | Open-market sale | −227,431 | $2.72 | $618,612 |
| Nov 12, 2025 | Brian Jg Pereira Director | Open-market sale | −27,595 | $2.72 | $75,058 |
| Jul 8, 2025 | Weber Darin J. Officer (Chief Regulatory Officer) | Open-market sale | −103,480 | $3.02 | $312,510 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.